

Short-read Sequencing Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The short-read sequencing market is experiencing significant growth, driven by advancements in technology and increasing applications in genomics, personalized medicine, and research. The market size is projected to reach approximately $8 billion by 2026, reflecting a compound annual growth rate of around 15%. Favorable market conditions support continued innovation and adoption.
◍ Thermo Fisher Scientific
◍ Hoffmann-La Roche AG
◍ GE healthcare
◍ Fasteris SA
◍ BGI Genomics
◍ Agilent Technologies
◍ Genscript Biotech Corporation
◍ Macrogen
◍ Genewiz
◍ Qiagen
◍ Illumina
The short-read sequencing market features key players like Illumina and Thermo Fisher Scientific, who drive growth through innovative products and services. Companies such as GE Healthcare and BGI Genomics enhance capabilities in genomics, while others like Agilent Technologies and Qiagen provide essential tools. Sales figures include Illumina: $3.5 billion, Thermo Fisher: $40 billion.
Request Sample Report
Academic Research ◍ Clinical Research
◍ Hospitals & Clinics
◍ Pharma & Biotech Entities ◍ Other
Request Sample Report
Instruments
Consumables
Services
Request Sample Report
$ X Billion USD